Drug Profile
Research programme: antibacterial therapeutics - AiCuris/Universities of Bochum, Bonn and Duesseldorf
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator AiCuris; Ruhr-University Bochum; University of Bonn; University of Duesseldorf
- Developer AiCuris; Ruhr-University Bochum; University of Bonn
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Bacterial-infections in Germany
- 30 Nov 2010 Early research in Bacterial infections in Germany (unspecified route)